Thank you to all who joined us live for PrimaryCareNOW on Thursday–Friday, June 10–11. If you were not able to join us, some sessions have been recorded and are available below.
Upcoming Virtual Conferences
Agenda
CME/CE Accredited Session
Non-CME/CE Session
Sponsored by Industry
Click For Session Details
Session Times Listed in ET
8–9am ET CME/CE Accredited Session
Jeffrey Rado, MD, MPH, FAPA
Bipolar disorder is common, affecting approximately 1% of the population. Individuals most often initially seek help in primary care settings, but diagnosis can be challenging even for seasoned clinicians. This presentation will review common and uncommon presentations of bipolar, including tips to making the diagnosis. Initial treatment strategies will also be discussed.
Jeffrey Rado, MD, MPH, FAPA
Associate Professor, Northwestern University, Feinberg School of Medicine, Chicago, IL
8–9am ET CME/CE Accredited Session
Lauren S. Blieden, MD
Ophthalmology emergencies in primary care can have profound consequences, and ruling out urgent referrals can be challenging. This session will provide you with a toolbox of tips and strategies to help triage urgent ophthalmic conditions in your practice.
Lauren S. Blieden, MD
Associate Professor & Vice-Chair of Education, Cullen Eye Institute, Baylor College of Medicine, Houston, TX
9:10–10:10am ET CME/CE Accredited Session
Clinical Considerations on Lipid Management of ASCVD in the New Era
Michael Miller, MD | Erin D. Michos, MD, MHS
This clinically-focused activity will interactively address many important clinical issues regarding the management of LDL cholesterol and elevated triglycerides with the goal of providing the insight, strategies, and practical guidance to effectively manage patients at high ASCVD risk. The expert faculty will compare clinical trial data on safety, tolerability, and different effects on lipid-lowering and cardio-protective benefits of the various treatment strategies available.
Michael Miller, MD
Professor of Cardiovascular Medicine, University of Maryland School of Medicine, Baltimore, MD
Erin D. Michos, MD, MHS
Associate Professor of Medicine & Epidemiology, Director of Women’s Cardiovascular Health, Associate Director of Preventive Cardiology, Ciccarone Center for the Prevention of Cardiovascular Disease, Johns Hopkins University School of Medicine, Baltimore, MD
Supported by Amarin Pharma Inc.
9:10–10:10am ET CME/CE Accredited Session
Armando G. Correa, MD, FAAP
This presentation will highlight recent developments and controversies in the pediatrics field by utilizing case-based discussions, and reviewing current evidence-based guidelines. Among the topics discussed, emphasis will be placed on the appropriate selection of antibiotics for common skin and soft tissue infections in the era of bacterial resistance. Additionally, this session will include a review of the impact that COVID-19 has had in the pediatric population, and the potential hesitancy that providers will encounter once a pediatric COVID-19 vaccine becomes available.
Armando G. Correa, MD, FAAP
Assistant Professor, Department of Pediatrics, Section of Academic General Pediatrics, Baylor College of Medicine, Medical Director, International and Destination Medicine, Texas Chilren's Hospital, Houston, TX
10:20–11:05am ET Non-CME Industry Theater
Developments in VTE Prophylaxis of Acutely Ill Medical Patients and Treatment of DVT/PE
Pamela Kushner, MD, FAAFP
Discussion on developments in VTE Prophylaxis of Acutely Ill Medical Patients and treatment of DVT/PE.
Pamela Kushner, MD, FAAFP
Clinical Professor, University of California Irvine Medical Center, Director, Kushner Wellness Center, Los Alamitos, CA
Sponsored by Janssen Pharmaceuticals, Inc.
10:20–11:05am ET Non-CME Industry Theater
An Overview of Bipolar I Disorder
David J. Scheiderer, MD, MBA, DFAPA
Please visit our product website, https://www.vraylarhcp.com.
David J. Scheiderer, MD, MBA, DFAPA
President, Tiberius Enterprises, Inc., Roanoke, Virginia
Sponsored by AbbVie
10:20–11:05am ET Non-CME Industry Theater
A Clinician’s Perspective on Managing Patients with COPD
Douglas W. Mapel, MD, MPH
Early and accurate diagnosis of chronic obstructive pulmonary disease (COPD) followed by optimal management are very important. This educational activity, will discuss the diagnosis of COPD, goals for treatment, pharmacological management, and the role of inhaled therapy and inhaler choice in the management of patients with COPD.
Douglas W. Mapel, MD, MPH
Adjunct Clinical Professor, College of Pharmacy , University of New Mexico, Albuquerque, NM , Critical Care Specialist & Pulmonologist , Critical Care Consultants of Arizona & Northern Arizona Pulmonary Associates , Northern Arizona Healthcare, Flagstaff, AZ
Sponsored by Boehringer Ingelheim Pharmaceuticals, Inc.
11:15am–12:15pm ET CME/CE Accredited Session
Paul E. Sax, MD | Laila Woc-Colburn, MD
These troubling times require communication among specialists and primary care. In this COVID-19 panel, primary care and infectious disease faculty will team up to discuss the most pressing and frequently asked questions about this disease and its complications.
Paul E. Sax, MD
Clinical Director, Division of Infectious Diseases, Brigham and Women's Hospital, Professor of Medicine, Harvard Medical School, Boston, MA
Laila Woc-Colburn, MD
Associate Professor, Division of Infectious Diseases, Emory University School of Medicine, Atlanta, GA
11:15am–12:15pm ET CME/CE Accredited Session
Marco Marcelli, MD
Throughout this 60-minute session, we will discuss a number of cases where correct interpretation of the clinical presentation and thyroid function tests leads to the correct diagnosis and treatment.
Marco Marcelli, MD
Professor of Medicine, Baylor College of Medicine, Acting Chief, Division of Endocrinology, Baylor College of Medicine, Chief Endocrine Services, Michael DeBakey VA Medical Center
12:25–1:25pm ET CME/CE Accredited Session
Fatima Cody Stanford, MD, MPH, MPA, FAAP, FACP, FTOS | Gregory L. Hall, MD | Sammy Saab, MD, MPH, AGAF
What do primary care providers need to know about managing pre/post bariatric surgery, health disparities, and HCV? Join obesity medicine physician scientist Fatima Cody Stanford, primary care physician Gregory Hall, and gastroenterologist Sammy Saab, as they review important questions they get asked about these topics!
Fatima Cody Stanford, MD, MPH, MPA, FAAP, FACP, FTOS
Obesity Medicine Physician Scientist, Massachusetts General Hospital and Harvard Medical School, Boston, MA
Gregory L. Hall, MD
Associate Professor of Integrative Medical Sciences, Northeast Ohio Medical University, Rootstown, OH, Associate Professor of Internal Medicine, Northeast Ohio Medical University, Rootstown, OH, Assistant Clinical Professor in Medicine, Case Western Reserve University School of Medicine, Cleveland, OH, Director, Center for African American Health, Research, Education & Policy, Cleveland, OH
Sammy Saab, MD, MPH, AGAF
Professor, Medicine and Surgery, David Geffen School of Medicine at UCLA, Los Angeles, CA, Head, Outcomes Research in Hepatology, David Geffen School of Medicine at UCLA, Los Angeles, CA
12:25–1:25pm ET CME/CE Accredited Session
Aanand D. Naik, MD | Kyler M. Godwin, PhD, MPH
What do primary care providers need to know about the foundations in quality improvement? Join geriatrician Aanand Naik and quality improvement expert Kyler Godwin as they review important questions they get asked about these topics!
Aanand D. Naik, MD
Professor and Luchi Chair in Geriatric Medicine, Baylor College of Medicine, Houston, TX
Kyler M. Godwin, PhD, MPH
Assistant Professor of Medicine and Assistant Director of Education, Institute for Continuing Professional Development in Quality Improvement and Patient Safety, Baylor College of Medicine, Houston, TX
1:35–2:20pm ET Non-CME Industry Theater
The Impact and Management of Moderate-to-Severe Atopic Dermatitis in Appropriate Patients
Michael J. Payette, MD, MBA, FAAD
Come learn about the burden and management of uncontrolled, moderate-to-severe atopic dermatitis in your appropriate patients and a treatment option that may help them.
@2021 Sanofi and Regeneron Pharmaceuticals, Inc. All Rights Reserved 03/2021 DER.21.03.0013
Michael J. Payette, MD, MBA, FAAD
Founding Partner, Central Connecticut Dermatology, Cromwell, CT, , Investigator, CCD Research, Cromwell, CT, , Associate Clinical Professor, Department of Dermatology, University of Connecticut, Farmington, Connecticut
Sponsored by Regeneron and Sanofi Genzyme
1:35–2:20pm ET Non-CME Industry Theater
Uncontrolled Asthma: Changing the Patient Experience
Neil Skolnik, MD
This session will use a case presentation to discuss the impact of uncontrolled asthma and tools for assessing asthma control as well as asthma management. Learn to identify ways to customize management of uncontrolled asthma by exploring medication options for appropriate patients.
Neil Skolnik, MD
Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University, Associate Director, Family Medicine Residency Program, Abington Jefferson Health
Sponsored by GlaxoSmithKline
1:35–2:20pm ET Non-CME Industry Theater
The Continuum of Heart Failure
James O'Keefe, MD
The objective of this program is to discuss the pathophysiology, disease burden, and management of heart failure (HF). The program will present data on HF prevalence and health outcomes, review the implications of type 2 diabetes as a common comorbidity, and provide guidance on diagnosing HF. It will conclude with a brief overview of current treatment options for HF.
James O'Keefe, MD
Director of Cardio Wellness Center, Saint Luke’s Mid America Heart Institute, Professor of Medicine, University of Missouri-Kansas City, Kansas City, Missouri
Sponsored by Boehringer Ingelheim Pharmaceuticals, Inc. and Lilly USA, LLC
2:30–3:30pm ET CME/CE Accredited Session
Rashmi B. Halker Singh, MD, FAHS, FAAN | Rajeev Raghavan, MD | Lee A. Lindquist, MD, MPH, MBA
What do primary care providers need to know about migraine, CKD, and deprescribing? Join neurologist Rashmi Halker Singh, nephrologist Rajeev Raghavan, and geriatrician Lee Lindquist as they review important questions they get asked about these topics!
Rashmi B. Halker Singh, MD, FAHS, FAAN
Associate Professor of Neurology, Director, Headache Medicine Fellowship Program, Division of Headache Medicine, Department of Neurology, Mayo Clinic, Scottsdale, AZ
Rajeev Raghavan, MD
Associate Professor of Medicine, Baylor College of Medicine, Houston, TX
Lee A. Lindquist, MD, MPH, MBA
Chief of Geratrics, Northwestern University Feinberg School of Medicine, Chicago, IL
2:30–3:30pm ET CME/CE Accredited Session
Meroë B. Morse, MD | Krishna B. Shah, MD
Throughout this 60-mintute session, learners will broaden their multimodal toolkit for pain management using a case-based format of three common pain conditions seen in the primary care setting. Participants will hear from two collaborating presenters: a primary care physician and a board-certified, pain-trained anesthesiologist, who manage and collaborate on patients with pain conditions. Emphasis will be placed on the evidence in support of non-opioid therapies for pain management, including pharmacologic, non-pharmacologic, and interventional strategies.
Meroë B. Morse, MD
Assistant Professor, Integrative Internal Medicine-Primary Care, Baylor College of Medicine, Houston, TX
Krishna B. Shah, MD
Assistant Professor, Director of Interventional Pain, Department of Anesthesiology, Baylor College of Medicine, Houston, TX
3:40–4:40pm ET CME/CE Accredited Session
Arun J. Ramappa, MD
This session will provide a clear, thoughtful approach to shoulder pain and offer pearls for rapid diagnosis and management. Key concepts will include a review of important structures around the shoulder that can cause pain and the positive impact of ergonomics. The speaker will also discuss decision-making for management and referral.
Arun J. Ramappa, MD
Chief of Sports Medicine and Shoulder Surgery, Beth Israel Deaconess Medical Center, Associate Professor of Orthopedic Surgery, Harvard Medical School, Boston, MA
3:40–4:40pm ET CME/CE Accredited Session
Richard J. Hamill, MD | Edward Lee Poythress, MD
What do primary care providers need to know about wound care and the diabetic foot? Join infectious disease expert Richard Hamill, and internist Edward Lee Poythress, as they review important questions they get asked about these topics!
Richard J. Hamill, MD
Professor, Departments of Medicine and Molecular Virology & Microbiology, Vice-Chair for Education, Department of Medicine, Baylor College of Medicine, Staff Physician, Infectious Diseases Section, Michael E. DeBakey VA Medical Center
Edward Lee Poythress, MD
Director, Wound Care Clinical Ben Taub Hospital, Associate Professor of Medicine, Baylor College of Medicine, Houston, TX
4:50–5:35pm ET Non-CME Industry Theater
Progression of CKD - Opportunties for Prevention Intervention and Mitigation
Victor Howard, MD, FACC
- Recognize the health burden and prevalence of CKD
- Understand CKD risk factors and the progressive nature of renal function decline
- Identify the risk of CKD in patients with T2D
- Review screening and monitoring recommendations in CKD
- Highlight current approaches to the management of CKD
Victor Howard, MD, FACC
Senior Medical Director, Cardiovascular US Medical Affairs, AstraZeneca
Dr. Howard was born in Charleston, West Virginia and is the second eldest of five siblings. His family moved to Texas at an early age, but ultimately all transitioned to Florida. He received his Bachelor of Science undergraduate degree and medical degree from the University of Miami with AΩA honors. He completed his residency in Internal Medicine at Parkland Hospital/University of Texas Southwestern Medical School in Dallas, Texas. He completed his fellowship in cardiology at the Methodist Hospital/Texas Medical Ctr., Baylor College of Medicine in Houston, Texas. He returned to Florida to practice general and interventional cardiology on the southwest coast of Florida for over 28 years. After a few years in a multispecialty practice he transitioned to building the largest single specialty practice in the state of Florida based in Sarasota. During that time he developed a highly regarded cardiology practice, but also was extensively involved in education, external consultation, and participation in over 60 clinical research trials. In March, 2014 he transitioned to a field medical directorship in the cardiovascular division of medical affairs at Astra Zeneca. His primary responsibility is to provide scientific and clinical expertise with respect to brand medical strategy as well as to develop enhanced peer relationships with physicians and institutions in the cardiovascular arena. His involvement extends to areas such as investigator sponsored research, support of clinical trials and major conferences/advisory boards and education. He resides in Sarasota, Florida with his wife Tiffany and three children Nathan, Nick, and Sophia. He enjoys the symphony, opera, and theater as well as spending time with his family whether it be relaxing on the beach or hiking and skiing in the mountains.
Sponsored by AstraZeneca
8–9am ET CME/CE Accredited Session
COVID-19 Vaccines: Science vs. Anti-Science
Peter J. Hotez, MD, PhD
Globally, we are seeing a mixed picture of vaccinating the United States and the world against COVID-19, with tremendous progress containing the B.1.1.7 variant in the United States but failing to control widespread transmission in Africa and Latin America. Dr. Hotez will discuss the progress made to date with the US vaccination program, what we can expect toward the end of 2021 and into 2022, and how we can advance vaccinations globally. This session will also explore the impact of a rising and shifting anti-vaccine movement.
Peter J. Hotez, MD, PhD
Dean, National School of Tropical Medicine, Professor, Departments of Pediatrics, Molecular Virology & Microbiology, Co-Head, Section of Pediatric Tropical Medicine, Health Policy Scholar, Baylor College of Medicine, Houston, TX
9:10–10:10am ET CME/CE Accredited Session
Atul Deodhar, MD, DNP, FACR, FACP | M.E. Beth Smith, DO, FACP
Axial spondyloarthritis/ankylosing spondylitis (axSpA/AS) imparts a significant burden on patients and caretakers. It negatively affects not only patient well-being and quality of life but also productivity during the prime of patients’ working lives. PCPs at the frontlines of care for patients with back pain are ideally positioned to identify individuals who may be suffering from axSpA/AS. Identification relies on a thorough understanding of the disease and its characteristics in addition to a high index of suspicion. This education will help PCPs to shorten the delay between symptom presentation and diagnosis and to improve rates of referral to rheumatology for diagnostic evaluation and confirmation.
Atul Deodhar, MD, DNP, FACR, FACP
Professor of Medicine, Medical Director, Rheumatology Clinics, Division of Arthritis and Rheumatic Diseases, Oregon Health & Science University, Portland, OR
M.E. Beth Smith, DO, FACP
Associate Professor of Medicine, School of Medicine, Oregon Health & Science University, Portland, OR
Supported by AbbVie Inc.
9:10–10:10am ET CME/CE Accredited Session
Maria Monica Gramatges, MD, PhD | Julie Nangia, MD
Dr. Nangia will discuss cancer survivorship, and will review what long term follow-up cancer patients need. This section will also cover potential long term and late adverse events cancer patients can experience and how to manage them. Learn what survivorship care plans are and how they can help primary care providers.
Dr. Gramatges will present an overview of late effects experienced by survivors of childhood cancer, focusing on general patterns, common outcomes, and excess morbidity/mortality risk. She will also discuss follow up patterns and distribution (primary care vs. oncology specialty care), need for subspecialty care, and the concept of a ‘shared-care’ model. Dr. Gramatges will introduce the evidence-based guidelines for childhood cancer survivors, where they may be accessed for public use, and strategies for guidelines dissemination and adherence, such as Passport for Care.
Maria Monica Gramatges, MD, PhD
Associate Professor of Pediatrics, Baylor College of Medicine, Houston, TX
Julie Nangia, MD
Medical Director Breast Oncology, Dan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX
10:20–11:05am ET Non-CME Industry Theater
Exacerbations of COPD: Consequences and Considerations
Stephen A. Brunton, MD, FAAFP
Uncovering the burden of COPD exacerbations may help in generating an appreciation of the range of associated consequences to the patient. This program will define exacerbation severity in COPD, review the possible impact of both moderate and severe COPD exacerbations, and highlight important considerations for appropriate COPD management.
Stephen A. Brunton, MD, FAAFP
Executive Vice President, Primary Care Education Consortium, Winnsboro, SC
Sponsored by AstraZeneca
10:20–11:05am ET Non-CME Industry Theater
Linking Chronic Kidney Disease (CKD) and Diabetes: Relationship, Challenges, and Burden of Disease
Arnold L. Silva, MD, PhD
Learn more about the relationship between chronic kidney disease (CKD) and diabetes, and the impact of these comorbidities on patients. This presentation will review the definition, clinical characteristics, and epidemiology of CKD. It will explore the implications of diabetes as a coexisting morbidity and discuss challenges that patients and healthcare providers face in managing these concurrent conditions. Additionally, it will highlight the importance of a collaborative approach to care for patients with CKD and diabetes.
Arnold L. Silva, MD, PhD
Director of Clinical Research, Boise Kidney and Hypertension Institute
Sponsored by Boehringer Ingelheim Pharmaceuticals, Inc. and Lilly USA, LLC
10:20–11:05am ET Non-CME Industry Theater
Abena Osei-Wusu, MD, FACC, FSCAI | Mark Stampehl, MD, FACC, FHFSA
This program follows two patients on their cardiovascular disease (CVD) journeys. Risk factors leading to the development and progression of atherosclerotic CVD and heart failure are discussed in the context of the patient experience over time. Strategies for primary and secondary prevention and optimization of guideline-directed medical therapy are also highlighted.
Abena Osei-Wusu, MD, FACC, FSCAI
Medical Director, Atherosclerosis, Cardiovascular, Renal & Metabolism Medical Unit, Novartis Pharmaceuticals Corporation
Mark Stampehl, MD, FACC, FHFSA
Executive Medical Director, Cardiovascular, Renal & Metabolism Medical Unit, Novartis Pharmaceuticals Corporation
Sponsored by Novartis Pharmaceuticals Corporation
11:15am–12:15pm ET CME/CE Accredited Session
"My Belly Hurts and I'm Having Bowel Problems": Stepping Up Treatment of Irritable Bowel Syndrome and Chronic Idiopathic Constipation
Philip Schoenfeld, MD, MSEd, MSc
This activity will provide an evidence-based approach to the diagnosis and management of irritable bowel syndrome (IBS) and chronic idiopathic constipation (CIC), with minimal diagnostic testing. The faculty will describe evidence-based treatment guidelines and discuss the efficacy of over-the-counter and prescription agents prioritized within the guidelines. This will help you navigate the progress from patient education to diet plus over-the-counter agents to prescription agents.
Philip Schoenfeld, MD, MSEd, MSc
Chief (Emeritus) - Gastroenterology Section, John D. Dingell VA Medical Center, Detroit, MI
Supported by Allergan and Ironwood Pharmaceuticals, Inc. Salix Pharmaceuticals
11:15am–12:15pm ET CME/CE Accredited Session
Clifford C. Dacso, MD, MPH | Stacey Rose, MD, FACP
What do primary care providers need to know about telehealth, burnout, and wellness? Join infectious disease experts Clifford Dacso and Stacey Rose as they review important questions, they get asked about these topics!
Clifford C. Dacso, MD, MPH
Jr. Professorof Molecular and Cellular Biology and Medicine, Philip J. Carroll, Baylor College of Medicine, Houston, TX
Stacey Rose, MD, FACP
Assistant Dean of Clinical Curriculum, Baylor College of Medicine, School of Medicine, Assistant Professor of Infectious Diseases, Baylor College of Medicine, Houston, TX
12:25–1:55pm ET CME/CE Accredited Session
Ty J. Gluckman, MD, FACC, FAHA | Karol E. Watson, MD, PhD
Do you have questions about startegies to prevent cardiovascular disease in your patients?
Dietary supplements are used by more than half of adult Americans, often with the hope that they are decreasing disease risk. Many of these supplements have undergone rigorous evaluation to assess their effect on cardiovascular outcomes. During this overview, cardiologist Dr. Ty Gluckman will review the clinical rationale for many dietary supplements and associated cardiovascular outcomes data.
Management of hypertension is one of the most important strategies for preventing cardiovascular disease. During this session, cardiologist Dr. Karol Watson will discuss the appropriate way to screen for hypertension and review strategies to prevent hypertension.
Following their presentation, speakers will answer questions from the audience.
Ty J. Gluckman, MD, FACC, FAHA
Medical Director, Center for Cardiovascular Analytics, Research, and Data Science (CARDS),, Providence Heart Institute, Providence St. Joseph Health, Portland, OR
Karol E. Watson, MD, PhD
Professor of Medicine/Cardiology, David Geffen School of Medicine at UCLA, Co-director, UCLA Program in Preventive Cardiology, David Geffen School of Medicine at UCLA, Director, UCLA Barbra Streisand Women's Heart Health Program, David Geffen School of Medicine at UCLA, Los Angeles, CA
12:25–1:55pm ET CME/CE Accredited Session
Sunjay R. Devarajan, MD | Anupam Kumar, MD, FCCP
Human beings have understood the effects of chronic obstructive pulmonary disease (COPD) for centuries. Dozens of medications and interventions have been approved and prescribed to combat these diseases, and treatments strategies have been developed that depend largely on severity of symptoms and disease staging. In this discussion, Dr. Devarajan will review the staging of COPD and how staging ties into optimal treatments. We will also spend some time reviewing useful prognostic scores, lung cancer screening practices in 2021, and the approach to the breathless patient.
Dr. Kumar will focus on the topic of essential basics of interstitial lung diseases for the community of physicians and other clinical healthcare professionals. This will include an overview of various types of interstitial lung diseases with brief discussion on clinical features and radiographic features that distinguish them from each other. This presentation will also highlight some of the newer therapies and advanced treatment options.
Sunjay R. Devarajan, MD
Assistant Professor, Division of Pulmonary & Critical Care, Baylor College of Medicine, Houston, TX
Anupam Kumar, MD, FCCP
Assistant Professor of Medicine, Division of Pulmonary & Critical Care, Baylor College of Medicine, Houston, TX
2:05–2:50pm ET Non-CME Industry Theater
Shifting Perspectives: How Do You Choose the Next Oral Therapy for T2D?
James R. LaSalle, DO, FAAFP
Review the pathophysiology of T2D and the recommendations from relevant associations on the oral treatment options that should be used after metformin in the T2D treatment plan. Discuss head-to-head data for a once-daily treatment option from pivotal glycemic control trials and safety data from a cardiovascular outcomes trial, followed by dosing and administration information.
James R. LaSalle, DO, FAAFP
Medical Arts of Excelsior Springs, Inc., Excelsior Springs, Missouri
Sponsored by Novo Nordisk Inc.
2:05–2:50pm ET Non-CME Industry Theater
Revisiting the Use of Oral Corticosteroids in Asthma: Benefits and Risks
David A. Queen, APRN, FNPC, BCMAS, MSL-BC, AE-C
- Review updated treatment paradigms for severe asthma
- Evaluate the benefit-risk of oral corticosteroid use in severe uncontrolled asthma and the need for OCS stewardship
- Discuss the role of biologics as a preferred treatment option for severe asthma management
David A. Queen, APRN, FNPC, BCMAS, MSL-BC, AE-C
Senior Medical Science Liaison, Respiratory & Immunology, South Texas, U.S. Medical Affairs
David Queen is a Senior Medical Science Liaison on the respiratory and immunology field medical affairs team at AstraZeneca. Mr. Queen board certified as a Family Nurse Practitioner, medical affairs specialist, medical science liaison, and asthma educator. He has over 15 years of clinical experience in the areas of allergy, asthma and immunology, urgent care, pediatrics, and critical care. Mr. Queen actively participates in regional and national conferences and supports asthma and COPD education across south Texas. He is a graduate of the Family Nurse Practitioner program at the University of Texas at Austin and is currently enrolled in the Doctor of Nursing Practice (DNP) program at Wichita State University.
Sponsored by AstraZeneca
2:05–2:50pm ET Non-CME Industry Theater
Giles F. Whalen, MD | Thomas C. King, MD, PhD
During this presentation, Dr. Giles Whalen, a Surgical Oncologist, will review which patients are at highest risk for developing pancreatic cancer and how primary care providers can assist those patients. Dr. Whalen will also review which patients should be referred for genetic counseling or to a high risk screening program for pancreatic cancer surveillance. Dr. Tom King will then provide an overview of the IMMray® PanCan-d test, a blood test for the early detection of pancreatic ductal adenocarcinoma in individuals at high risk for developing familial or hereditary pancreatic cancer.
Giles F. Whalen, MD
Professor of Medicine, University of Massachusetts Medical School
Chief, Division of Surgical Oncology, UMASS Memorial Medical Center, Worcester, Massachusetts
Thomas C. King, MD, PhD
Medical Director, Immunovia, Inc.
Adjunct Associate Professor, School of Health Professions, Rutgers, the State University of New Jersey
Sponsored by Immunovia, Inc.
3–4pm ET CME/CE Accredited Session
Daniel A. Solomon, MD
In this presentation on Lyme and other tickborne diseases, Dr. Solomon will review the clinical approach to patients with suspected tickborne disease. He will focus on a comprehensive review of Lyme disease including the clinical manifestations, the challenges and pitfalls in diagnostic testing, prevention of Lyme through the use of post-exposure prophylaxis, and the potential co-infections carried by the same vector. He will review the evidence on management of Post-Treatment Lyme Disease Syndrome and offer a rational approach to treatment. Finally, he will discuss the social controversy around “Chronic Lyme.”
Daniel A. Solomon, MD
Associate Physician, Division of Infectious Diseases
Brigham and Women's Hospital
Instructor of Medicine
Harvard Medical School
Boston, MA
3–4pm ET CME/CE Accredited Session
R. Michelle Schmidt, MD, MPH
Throughout this 60-minute session, learners will review cases that are commonly seen in an urgent care setting, understand problems that are frequently encountered in an urgent care, and know how to best approach these issues to benefit both the health care provider and the patient. Participants will learn when patients may avoid a trip to the urgent care center and when providers should refer to a specialist. Additionally, learners will review cases that highlight certain problems that primary care providers may encounter in their practices.
R. Michelle Schmidt, MD, MPH
Assistant Professor, Section of General Medicine, Baylor College of Medicine, Houston, TX
4:10–5:10pm ET CME/CE Accredited Session
Martin J. Abrahamson, MD, FACP | Jacob Levitt, MD, FAAD
What do primary care providers need to know about type 2 diabetes, acne, and rosacea? Join Dr. Martin Abrahamson and Dr. Jacob Levitt as they review important questions they get asked about these topics!
Martin J. Abrahamson, MD, FACP
Associate Professor of Medicine, Harvard Medical School, Director, Division of CME, Beth Israel Deaconess Medical Center, Boston, MA
Jacob Levitt, MD, FAAD
Professor and Vice Chairman, Department of Dermatology, Mount Sinai Medical Center, New York, NY
4:10–5:10pm ET CME/CE Accredited Session
Mohit Khera, MD, MBA, MPH
Aging men often experience three conditions which are strongly associated with one another. These conditions are hypogonadism, BPH, and erectile dysfunction. It is not uncommon for older men to have all three of these conditions. The aim of this presentation is to give a better understanding of how to diagnose and treat men with BPH, hypogonadism, and erectile dysfunction. In addition, Dr. Khera will highlight the key concepts from the 2018 American Urologic Association (AUA) ED Guidelines and the 2018 AUA Testosterone Guidelines.
Mohit Khera, MD, MBA, MPH
Professor of Urology, Scott Department of Urology, Baylor College of Medicine, Houston, TX
5:20–6:05pm ET Non-CME Industry Theater
A Treatment Option for Adult Patients with Insomnia
Damon Raskin, MD
In a presentation with Dr. Raskin, learn about the pivotal clinical data and a pilot study that evaluated the next-dose transition from a treatment to this treatment option.
Damon Raskin, MD
Physician in Private Practice Pacific Palisades, CA
Sponsored by Eisai Inc.